Credit Suisse’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $4.74M | Sell |
80,642
-4,929
| -6% | -$290K | ﹤0.01% | 1320 |
|
|
2023
Q4 | $5.12M | Sell |
85,571
-1,442
| -2% | -$86.3K | ﹤0.01% | 1308 |
|
|
2023
Q3 | $3.31M | Sell |
87,013
-6,870
| -7% | -$261K | ﹤0.01% | 1517 |
|
|
2023
Q2 | $8.55M | Buy |
93,883
+9,935
| +12% | +$905K | 0.01% | 990 |
|
|
2023
Q1 | $5.54M | Buy |
83,948
+7,040
| +9% | +$464K | 0.01% | 1224 |
|
|
2022
Q4 | $3.98M | Buy |
76,908
+38
| +0% | +$1.97K | ﹤0.01% | 1435 |
|
|
2022
Q3 | $5.25M | Buy |
76,870
+12,108
| +19% | +$827K | 0.01% | 1211 |
|
|
2022
Q2 | $2.93M | Sell |
64,762
-5,504
| -8% | -$249K | ﹤0.01% | 1637 |
|
|
2022
Q1 | $3.57M | Buy |
70,266
+7,234
| +11% | +$368K | ﹤0.01% | 1677 |
|
|
2021
Q4 | $2.98M | Buy |
63,032
+3,845
| +6% | +$182K | ﹤0.01% | 1862 |
|
|
2021
Q3 | $1.95M | Buy |
59,187
+13,459
| +29% | +$444K | ﹤0.01% | 2163 |
|
|
2021
Q2 | $2.89M | Sell |
45,728
-2,480
| -5% | -$157K | ﹤0.01% | 1918 |
|
|
2021
Q1 | $2.07M | Sell |
48,208
-42,362
| -47% | -$1.82M | ﹤0.01% | 2126 |
|
|
2020
Q4 | $5.18M | Sell |
90,570
-14,852
| -14% | -$850K | ﹤0.01% | 1500 |
|
|
2020
Q3 | $3.18M | Sell |
105,422
-22,177
| -17% | -$669K | ﹤0.01% | 1536 |
|
|
2020
Q2 | $4.17M | Buy |
127,599
+73,083
| +134% | +$2.39M | ﹤0.01% | 1391 |
|
|
2020
Q1 | $1.46M | Sell |
54,516
-5,872
| -10% | -$157K | ﹤0.01% | 1844 |
|
|
2019
Q4 | $1.85M | Buy |
60,388
+8,848
| +17% | +$271K | ﹤0.01% | 2092 |
|
|
2019
Q3 | $1.24M | Buy |
51,540
+22,815
| +79% | +$550K | ﹤0.01% | 2259 |
|
|
2019
Q2 | $728K | Buy |
28,725
+4,885
| +20% | +$124K | ﹤0.01% | 2561 |
|
|
2019
Q1 | $464K | Buy |
23,840
+4,284
| +22% | +$83.4K | ﹤0.01% | 2808 |
|
|
2018
Q4 | $258K | Buy |
19,556
+5,987
| +44% | +$79K | ﹤0.01% | 3050 |
|
|
2018
Q3 | $241K | Sell |
13,569
-966
| -7% | -$17.2K | ﹤0.01% | 3127 |
|
|
2018
Q2 | $320K | Buy |
+14,535
| New | +$320K | ﹤0.01% | 3147 |
|